MétaCan
Menu
Back to cohort
Record W4417362291 · doi:10.1093/eurheartj/ehaf947

Combined clinical, metabolomic, and polygenic scores for cardiovascular risk prediction

2025· article· en· W4417362291 on OpenAlexfundno aff
Scott C. Ritchie, Xilin Jiang, Lisa Pennells, Yu Xu, C. Coffey, Yang Liu, Joel T. Gibson, Praveen Surendran, Savita Karthikeyan, Samuel A. Lambert, John Danesh, Adam S. Butterworth, Angela Wood, Stephen Kaptoge, Emanuele Di Angelantonio, Michael Inouye

Bibliographic record

VenueEuropean Heart Journal · 2025
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicMetabolomics and Mass Spectrometry Studies
Canadian institutionsnot available
FundersScottish Government Health and Social Care DirectorateMedical Research CouncilPublic Health AgencyDepartment of Health and Social CareEngineering and Physical Sciences Research CouncilCanadian Institutes of Health ResearchHealth and Social Care Research and Development DivisionNational Institute for Health and Care ResearchDell EMCWellcome TrustScience and Technology Facilities CouncilBritish Heart FoundationNIHR Cambridge Biomedical Research CentreEconomic and Social Research Council
KeywordsPopulationPolygenic risk scoreDiseaseMEDLINERisk assessmentCardiovascular health

Abstract

fetched live from OpenAlex

BACKGROUND AND AIMS: Clinical biomarkers, nuclear magnetic resonance (NMR) metabolomics biomarker scores, and polygenic risk scores (PRS) have shown promise for improving cardiovascular disease (CVD) prediction but have not yet been evaluated in the context of current prediction models (SCORE2) and ESC recommendations for 10-year prediction of fatal and non-fatal CVD. METHODS: NMR metabolomic biomarker scores were constructed and compared to clinical biomarkers, PRS and SCORE2 in 297 463 UK Biobank participants (8919 incident CVD cases) aged 40-69 without previous CVD, diabetes, or lipid-lowering treatment. Improvement in risk discrimination when added to SCORE2 was assessed using Harrel's C-index. Improvement in risk stratification following ESC guideline risk thresholds was assessed using categorical net reclassification. Population modelling was subsequently applied to estimate the impact on CVD prevention if applied at scale. RESULTS: Risk discrimination provided by SCORE2 (C-index: 0.719) improved when 11 clinical biomarkers (ΔC-index: 0.014 [0.012-0.015]), NMR metabolomic biomarker scores (ΔC-index: 0.010 [0.009-0.012]) and PRSs (ΔC-index 0.009; [0.008-0.011]) were added individually. The combination of 11 clinical biomarkers, NMR metabolomic biomarker scores, and PRSs yielded the largest improvement risk discrimination, with ΔC-index 0.024 (0.022-0.027). Concomitant improvements in risk stratification were observed in categorical net reclassification index, with net case reclassification of 16.66% (15.50%-17.81%). Modelling suggested that addition of these biomarkers to SCORE2 for targeted risk reclassification would increase the number of CVD events prevented per 100 000 screened from 229 to 413 (ΔCVDprevented: 184 [174-194]) while essentially maintaining the number of statins prescribed per CVD event prevented. CONCLUSIONS: Combining NMR metabolomic, polygenic, and clinical biomarkers with SCORE2 enhanced prediction of first-onset CVD and could have substantial population health benefit if applied at scale.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.015
metaresearch head score (Gemma)0.021
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Simulation or modeling · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.015
Threshold uncertainty score0.080

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0150.021
Meta-epidemiology (narrow)0.0020.000
Meta-epidemiology (broad)0.0020.003
Bibliometrics0.0030.003
Science and technology studies0.0000.001
Scholarly communication0.0020.001
Open science0.0010.002
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.025
GPT teacher head0.303
Teacher spread0.278 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSimulation or modeling
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations6
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueEuropean Heart JournalSame topicMetabolomics and Mass Spectrometry StudiesFrench-language works237,207